[HTML][HTML] Cannabinoid products for pain management: recommendations from the São Paulo State Society of Anesthesiology
GAM de Barros, AM Pos, ÂM Sousa, CL Pereira… - Brazilian Journal of …, 2024 - Elsevier
There is growing interest in using cannabinoids across various clinical scenarios, including
pain medicine, leading to the disregard of regulatory protocols in some countries …
pain medicine, leading to the disregard of regulatory protocols in some countries …
Cannabinoid products for pain management: recommendations from the São Paulo State Society of Anesthesiology
GAM de Barros, AM Pos, ÂM Sousa… - Brazilian Journal of …, 2024 - rba.periodikos.com.br
There is growing interest in using cannabinoids across various clinical scenarios, including
pain medicine, leading to the disregard of regulatory protocols in some countries …
pain medicine, leading to the disregard of regulatory protocols in some countries …
Cannabinoid products for pain management: recommendations from the São Paulo State Society of Anesthesiology
GAM de Barros, AM Pos, ÂM Sousa… - Brazilian journal of … - pubmed.ncbi.nlm.nih.gov
There is growing interest in using cannabinoids across various clinical scenarios, including
pain medicine, leading to the disregard of regulatory protocols in some countries …
pain medicine, leading to the disregard of regulatory protocols in some countries …
[HTML][HTML] Cannabinoid products for pain management: recommendations from the São Paulo State Society of Anesthesiology
GAM de Barros, AM Pos, ÂM Sousa… - Brazilian Journal of …, 2024 - ncbi.nlm.nih.gov
There is growing interest in using cannabinoids across various clinical scenarios, including
pain medicine, leading to the disregard of regulatory protocols in some countries …
pain medicine, leading to the disregard of regulatory protocols in some countries …
Cannabinoid products for pain management: recommendations from the São Paulo State Society of Anesthesiology
GAM de Barros, AM Pos, ÂM Sousa… - Brazilian Journal of …, 2024 - rba.periodikos.com.br
There is growing interest in using cannabinoids across various clinical scenarios, including
pain medicine, leading to the disregard of regulatory protocols in some countries …
pain medicine, leading to the disregard of regulatory protocols in some countries …